IL-12 and GM-CSF engineered dendritic cells enhance the enrichment and selection of tumor-reactive T cells for cancer immunotherapy

IL-12 和 GM-CSF 工程化树突状细胞可增强肿瘤反应性 T 细胞的富集和选择，用于癌症免疫治疗。